Intractable Epilepsy clinical trials

Explore recruiting intractable epilepsy clinical trials.

Recruiting intractable epilepsy studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Intractable Epilepsy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC OLE)

Germany, Spain, Italy, France, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Intractable Epilepsy trials by city

Intractable Epilepsy clinical trials

Recruiting intractable epilepsy studies right now

Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy

Diagnosing Epilepsy To EffeCT Change

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

Neural Mechanisms of Spatial Representations Beyond the Self

Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial

Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies

Temporal Interference for Drug Resistant Epilepsy

Biomarkers of Response to SEEG Thermocoagulation

MEG Versus EEG HR for the Localization of the Epileptogenic Zone as Part of the Pre-surgical Assessment of Epilepsy

Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex

Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy

Hybrid Micro-macro Electrodes in Patients With Epilepsy

Also recruiting in Europe

A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC OLE)

Intractable Epilepsy trials by city

Other conditions